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A 29-year-old woman presented with bloody diarrhea,
abdominal pain, hemolytic anemia, thrombocytopenia, and
acute renal failure. She was diagnosed with Escherichia coli
O104:H4-associated hemolytic-uremic syndrome (HUS) and
treated with plasmapheresis and hemodialysis for 3 weeks. She
recovered without sequelae. To the best of our knowledge, this
is the first report of Escherichia coli O104:H4-associated HUS
in Korea. We recommend that Escherichia coli O104:H4, as
well as the more common O157:H7, be considered in the
diagnosis of bloody diarrhea-associated HUS.
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INTRODUCTION
Hemolytic uremic syndrome (HUS) is often
caused by enterohemorrhagic Escherichia coli
(EHEC) serogroup strains, mainly Escherichia coli
O157:H7. Recently, non-O157:H7 serotypes of
verotoxigenic Escherichia coli have been isolated,
although the majority of outbreaks and sporadic
cases in humans have been associated with sero-
type O157:H7.
1,2 In 1998, the isolation of an
Escherichia coli O157:H7 strain from a hemolytic
uremic syndrome patient was first reported in
Korea.
3 Thereafter, non-O157:H7 EHEC infections
associated with HUS have been reported,
4 but
EHEC O104:H4 infections have not yet been
reported in Korea.
We report the first case of Escherichia coli O104:
H4 associated HUS successfully treated with
plasma exchange and hemodialysis in Korea.
CASE REPORT
A 29-year-old woman was admitted to the
hospital with abdominal pain and bloody diar-
rhea. She was previously healthy and had no
specific past medical history. Stool culture was
performed and she received intravenous hydra-
tion. On hospital day 2, her urine volume de-
creased, and generalized edema developed. She
was transferred to Chonnam National University
Hospital (CNUH). Upon admission her blood
pressure was 120/70 mmHg, pulse rate was 72/
min, respiration rate was 32/min, and body tem-
perature was 36.6 . The abdomen was slightly
tender but not distended. Laboratory tests showed
a serum creatinine of 4.2 mg/dL, blood urea
nitrogen of 35.4 mg/dL, hemoglobin 9.2 g/dL,
platelet count 19,000/mm
3, corrected reticulocyte
count 5.4%, lactate dehydrogenase 3150 IU/L,
haptoglobin 7.69 mg/dL, total bilirubin 1.31 mg/
dL, and direct bilirubin 0.19 mg/dL. Peripheral
blood smear showed microangiopathic hemolytic
anemia (Fig. 1). A diagnosis of HUS was made
based on the occurrence of acute renal failure,
hemolytic anemia, and thrombocytopenia. Esche-
richia coli O104:H4 was identified in the stool
culture performed at the hospital where she was
first admitted by using polymerase chain reaction
for virulence-associated genes of EHEC, but other
EHEC related serogroups including Escherichia coli
O157:H7 were not found at Chonnam Institute of
Health and Environment. She received hemodi-
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alysis for four days, and plasma exchange and
fresh frozen plasma for two weeks. On hospital
day 14, tonic seizure occurred suddenly but was
not presented until the following day. The brain
computed tomography (CT) and electroencephalo-
gram (EEG) did not show any abnormalities. On
hospital day 20, her platelet count rose to 299,000/
mm
3, hemoglobin rose to 10.6 g/dL, reticulocyte
count dropped to 1.5%, lactate dehydrogenase
dropped to 507 IU/L, and blood urea nitrogen
and serum creatinine fell to 17.5 mg/dL and 1.0
mg/ dL, respectively. Peripheral blood smear did
not show evidence of hemolytic anemia. After
hospital day 21, two successive stool specimens
yielded negative results for Escherichia coli
O104:H4. On hospital day 27, she was discharged
and received follow-up care as an outpatient.
DISCUSSION
The pathotypes of intestinal pathogenic Esche-
richia coli are classified as follows : Shiga toxin-
producing Escherichia coli (STEC)/enterohemor-
rhagic Escherichia coli (EHEC), enterotoxigenic
Escherichia coli (ETEC), enteropathogenic Esche-
richia coli (EPEC), enteroinvasive Escherichia coli
(EIEC), enteroaggregative Escherichia coli (EAEC),
and diffusely adherent Escherichia coli (DAEC).
STEC/EHEC strains can cause hemorrhagic colitis
and HUS. EHEC O157:H7 has since been docu-
mented as the cause of both large outbreaks and
sporadic infections in the United States and
around the world. Several large outbreaks
resulted from the consumption of undercooked
ground beef and other foods. Our patient fre-
quently ate fast food, particularly hamburgers. We
could not exclude the possibility that EHEC
O104:H4 was transmitted by contaminated ham-
burger consumed by our patient. However, we
did not investigate the origins of the EHEC
O104:H4 infection Hemorrhagic colitis associated
with EHEC O157:H7 and others is characterized
by grossly bloody diarrhea, often with remarkably
little fever or inflammatory exudate in the stool.
Although the diarrheal illnesses have been self-
limiting, a significant number of children and
adults have subsequently developed a potentially
fatal hemolytic uremic syndrome or thrombotic
thrombocytopenic purpura.
5 The clinical mani-
festations of post-diarrheal HUS include renal
failure, microangiopathic hemolytic anemia, and
thrombocytopenia. Several studies reported that
the culture rate of EHEC O157:H7 was 2% to 51%
in post-diarrheal HUS.
6 HUS complicates 10% of
bloody diarrhea induced by EHEC. Some estimate
that EHEC causes at least 70% of post-diarrheal
HUS in the United States and that 80% of these
are caused by EHEC O157:H7, and the other 20%
by a different serotype of EHEC.
7,8 In Australia,
however, EHEC O157 infections are rare in
patients with post-diarrheal HUS and the majority
are caused by non-O157 EHEC. The use of anti-
motility agents in children under 10 years of age
or in elderly patients should be avoided as it
increases the risk of HUS with EHEC infections.
The incubation period has usually been 3 to 5
days after bloody diarrhea, but HUS infrequently
develops no prodromal symptom.
9 Although the
illness is usually self-limited, the mortality rate is
3 to 5% in young children and 30% of patients
with HUS develop permanent renal failure,
hypertension or neurologic sequelae.
10
Escherichia coli serotype O104:H21 infections
were documented in the United States, and other
EHEC O104:(H-, H2, H7, H21) infections were also
reported in several countries.
11-14 However EHEC
O104:H4 associated HUS has not yet been re-
ported. EHEC O104 associated HUS has not yet
been reported in Korea. So this is the first de-
scription of EHEC O104:H4 associated HUS in
Korea. EHEC O104:H4 produces a shiga-like toxin
Fig. 1. Peripheral blood smear showed polychromasia,
anisocytosis and schistocytes, consistent with microangio-
pathic hemolytic anemia (hematoxylin and eosin, × 400).HUS Caused by E. coli O104:H4
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(verocytotxin) that may cause direct renal and
endothelial cell damage and may adhere to intes-
tinal epithelium resulting in bloody diarrhea.
Thrombocytopenia occurs as a consequence of
platelet consumption, and hemolytic anemia
results from intravascular fibrin deposition, in-
creased red blood cell fragility, and fragmenta-
tion.
15
Plasma exchange, which removes the plasma
with the shiga-like toxin and its breakdown
products, may decrease the effects of the toxin.
This may be more effective than plasma infusion
alone.
16 In 1996, an outbreak of EHEC O157:H7-
related HUS demonstrated the potential efficacy
of plasma exchange in reducing mortality in the
elderly; 83% of those who did not have a plasma
exchange died compared with 31% who did
receive plasma exchange.
17
Although the role of plasma exchange in HUS
secondary to EHEC infection remains controver-
sial,
18 we suggest that plasma exchange may
improve the outcome in adult bloody diarrhea-
associated HUS. We also recommend that shiga
toxin producing bacterial infections including
EHEC O157:H7 and O104:H4 must be considered
in all bloody diarrhea prodrome HUS patients.
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